GlassScriptPhysician profile
Jay Raisen
NPI 1740305473
$3,509.64
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $439 · 2021: $2,083 · 2022: $336 · 2024: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $262.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,384.22 | 2020-2022 | |
| Preceptis Medical, INC. | $242.13 | 2019-2021 | |
| Alk-Abello, INC | $234.84 | 2019 | |
| Glaxosmithkline, LLC. | $225.98 | 2022-2024 | Nucala |
| Medtronic, INC. | $133.05 | 2024 | Propel, Bizact, Stealthstation S8 Platform |
| Astrazeneca Pharmaceuticals LP | $83.22 | 2019 | |
| Aerin Medical INC. | $74.12 | 2019-2022 | |
| Optinose US, INC. | $37.43 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $35.69 | 2024 | Dupixent |
| Intersect Ent, INC. | $30.37 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $28.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Raisen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.